Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party. [electronic resource]
Producer: 20171128Description: 31 p. digitalISSN:- 1756-8722
- Adolescent
- Adult
- Aged
- Antilymphocyte Serum -- therapeutic use
- Busulfan -- therapeutic use
- Female
- Graft vs Host Disease -- prevention & control
- HLA Antigens
- Hematopoietic Stem Cell Transplantation -- methods
- Histocompatibility -- immunology
- Humans
- Leukemia, Myeloid, Acute -- therapy
- Leukocyte Reduction Procedures
- Lymphocyte Depletion
- Male
- Middle Aged
- Myeloablative Agonists -- therapeutic use
- Retrospective Studies
- T-Lymphocytes
- Transplantation Conditioning -- methods
- Treatment Outcome
- Vidarabine -- analogs & derivatives
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.